ReviewBritish journal of pharmacology2005

Phase 2 ventricular arrhythmias in acute myocardial infarction: a neglected target for therapeutic antiarrhythmic drug development and for safety pharmacology evaluation.

Hugh Clements-Jewery et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.